391 related articles for article (PubMed ID: 27562971)
1. Metabolic Reprogramming Regulates the Proliferative and Inflammatory Phenotype of Adventitial Fibroblasts in Pulmonary Hypertension Through the Transcriptional Corepressor C-Terminal Binding Protein-1.
Li M; Riddle S; Zhang H; D'Alessandro A; Flockton A; Serkova NJ; Hansen KC; Moldovan R; McKeon BA; Frid M; Kumar S; Li H; Liu H; Caánovas A; Medrano JF; Thomas MG; Iloska D; Plecitá-Hlavatá L; Ježek P; Pullamsetti S; Fini MA; El Kasmi KC; Zhang Q; Stenmark KR
Circulation; 2016 Oct; 134(15):1105-1121. PubMed ID: 27562971
[TBL] [Abstract][Full Text] [Related]
2. Microenvironmental Regulation of Macrophage Transcriptomic and Metabolomic Profiles in Pulmonary Hypertension.
Li M; Riddle S; Kumar S; Poczobutt J; McKeon BA; Frid MG; Ostaff M; Reisz JA; Nemkov T; Fini MA; Laux A; Hu CJ; El Kasmi KC; D'Alessandro A; Brown RD; Zhang H; Stenmark KR
Front Immunol; 2021; 12():640718. PubMed ID: 33868271
[TBL] [Abstract][Full Text] [Related]
3. Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension Is Regulated Through a MicroRNA-124/PTBP1 (Polypyrimidine Tract Binding Protein 1)/Pyruvate Kinase Muscle Axis.
Zhang H; Wang D; Li M; Plecitá-Hlavatá L; D'Alessandro A; Tauber J; Riddle S; Kumar S; Flockton A; McKeon BA; Frid MG; Reisz JA; Caruso P; El Kasmi KC; Ježek P; Morrell NW; Hu CJ; Stenmark KR
Circulation; 2017 Dec; 136(25):2468-2485. PubMed ID: 28972001
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin is an endogenous modulator of the constitutively activated phenotype of pulmonary adventitial fibroblasts in hypoxic pulmonary hypertension.
Anwar A; Li M; Frid MG; Kumar B; Gerasimovskaya EV; Riddle SR; McKeon BA; Thukaram R; Meyrick BO; Fini MA; Stenmark KR
Am J Physiol Lung Cell Mol Physiol; 2012 Jul; 303(1):L1-L11. PubMed ID: 22582113
[TBL] [Abstract][Full Text] [Related]
5. Constitutive Reprogramming of Fibroblast Mitochondrial Metabolism in Pulmonary Hypertension.
Plecitá-Hlavatá L; Tauber J; Li M; Zhang H; Flockton AR; Pullamsetti SS; Chelladurai P; D'Alessandro A; El Kasmi KC; Ježek P; Stenmark KR
Am J Respir Cell Mol Biol; 2016 Jul; 55(1):47-57. PubMed ID: 26699943
[TBL] [Abstract][Full Text] [Related]
6. Metabolic reprogramming and inflammation act in concert to control vascular remodeling in hypoxic pulmonary hypertension.
Stenmark KR; Tuder RM; El Kasmi KC
J Appl Physiol (1985); 2015 Nov; 119(10):1164-72. PubMed ID: 25930027
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-124 controls the proliferative, migratory, and inflammatory phenotype of pulmonary vascular fibroblasts.
Wang D; Zhang H; Li M; Frid MG; Flockton AR; McKeon BA; Yeager ME; Fini MA; Morrell NW; Pullamsetti SS; Velegala S; Seeger W; McKinsey TA; Sucharov CC; Stenmark KR
Circ Res; 2014 Jan; 114(1):67-78. PubMed ID: 24122720
[TBL] [Abstract][Full Text] [Related]
8. C-Terminal Binding Protein 1 Modulates Cellular Redox via Feedback Regulation of MPC1 and MPC2 in Melanoma Cells.
Deng Y; Li H; Yin X; Liu H; Liu J; Guo D; Shi Z
Med Sci Monit; 2018 Oct; 24():7614-7624. PubMed ID: 30356033
[TBL] [Abstract][Full Text] [Related]
9. SIRT3 Is a Critical Regulator of Mitochondrial Function of Fibroblasts in Pulmonary Hypertension.
Li M; Plecitá-Hlavatá L; Dobrinskikh E; McKeon BA; Gandjeva A; Riddle S; Laux A; Prasad RR; Kumar S; Tuder RM; Zhang H; Hu CJ; Stenmark KR
Am J Respir Cell Mol Biol; 2023 Nov; 69(5):570-583. PubMed ID: 37343939
[TBL] [Abstract][Full Text] [Related]
10. TRPV4 channel mediates adventitial fibroblast activation and adventitial remodeling in pulmonary hypertension.
Cussac LA; Cardouat G; Tiruchellvam Pillai N; Campagnac M; Robillard P; Montillaud A; Guibert C; Gailly P; Marthan R; Quignard JF; Savineau JP; Ducret T
Am J Physiol Lung Cell Mol Physiol; 2020 Jan; 318(1):L135-L146. PubMed ID: 31693393
[TBL] [Abstract][Full Text] [Related]
11. Microenvironmental regulation of T-cells in pulmonary hypertension.
Plecitá-Hlavatá L; Brázdová A; Křivonosková M; Hu CJ; Phang T; Tauber J; Li M; Zhang H; Hoetzenecker K; Crnkovic S; Kwapiszewska G; Stenmark KR
Front Immunol; 2023; 14():1223122. PubMed ID: 37497214
[TBL] [Abstract][Full Text] [Related]
12. Emergence of fibroblasts with a proinflammatory epigenetically altered phenotype in severe hypoxic pulmonary hypertension.
Li M; Riddle SR; Frid MG; El Kasmi KC; McKinsey TA; Sokol RJ; Strassheim D; Meyrick B; Yeager ME; Flockton AR; McKeon BA; Lemon DD; Horn TR; Anwar A; Barajas C; Stenmark KR
J Immunol; 2011 Sep; 187(5):2711-22. PubMed ID: 21813768
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia induces unique proliferative response in adventitial fibroblasts by activating PDGFβ receptor-JNK1 signalling.
Panzhinskiy E; Zawada WM; Stenmark KR; Das M
Cardiovasc Res; 2012 Aug; 95(3):356-65. PubMed ID: 22735370
[TBL] [Abstract][Full Text] [Related]
14. Glycolysis Promotes Angiotensin II-Induced Aortic Remodeling Through Regulating Endothelial-to-Mesenchymal Transition via the Corepressor C-Terminal Binding Protein 1.
Wang L; Guo S; Cao K; Li Z; Li Z; Song M; Wang C; Chen P; Cui Y; Dai X; Feng D; Fu X; He J; Xu Y
Hypertension; 2023 Dec; 80(12):2627-2640. PubMed ID: 37795602
[TBL] [Abstract][Full Text] [Related]
15. A pathogenic CtBP1 missense mutation causes altered cofactor binding and transcriptional activity.
Beck DB; Subramanian T; Vijayalingam S; Ezekiel UR; Donkervoort S; Yang ML; Dubbs HA; Ortiz-Gonzalez XR; Lakhani S; Segal D; Au M; Graham JM; Verma S; Waggoner D; Shinawi M; Bönnemann CG; Chung WK; Chinnadurai G
Neurogenetics; 2019 Aug; 20(3):129-143. PubMed ID: 31041561
[TBL] [Abstract][Full Text] [Related]
16. Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-β in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension.
Tojais NF; Cao A; Lai YJ; Wang L; Chen PI; Alcazar MAA; de Jesus Perez VA; Hopper RK; Rhodes CJ; Bill MA; Sakai LY; Rabinovitch M
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1559-1569. PubMed ID: 28619995
[TBL] [Abstract][Full Text] [Related]
17. Complement-containing small extracellular vesicles from adventitial fibroblasts induce proinflammatory and metabolic reprogramming in macrophages.
Kumar S; Frid MG; Zhang H; Li M; Riddle S; Brown RD; Yadav SC; Roy MK; Dzieciatkowska ME; D'Alessandro A; Hansen KC; Stenmark KR
JCI Insight; 2021 Nov; 6(21):. PubMed ID: 34499621
[TBL] [Abstract][Full Text] [Related]
18. Adventitial fibroblasts induce a distinct proinflammatory/profibrotic macrophage phenotype in pulmonary hypertension.
El Kasmi KC; Pugliese SC; Riddle SR; Poth JM; Anderson AL; Frid MG; Li M; Pullamsetti SS; Savai R; Nagel MA; Fini MA; Graham BB; Tuder RM; Friedman JE; Eltzschig HK; Sokol RJ; Stenmark KR
J Immunol; 2014 Jul; 193(2):597-609. PubMed ID: 24928992
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitors synergize with sildenafil to suppress purine metabolism and proliferation in pulmonary hypertension.
Zhang H; D'Alessandro A; Li M; Reisz JA; Riddle S; Muralidhar A; Bull T; Zhao L; Gerasimovskaya E; Stenmark KR
Vascul Pharmacol; 2023 Apr; 149():107157. PubMed ID: 36849042
[TBL] [Abstract][Full Text] [Related]
20. Redox-dependent Brca1 transcriptional regulation by an NADH-sensor CtBP1.
Deng Y; Liu J; Han G; Lu SL; Wang SY; Malkoski S; Tan AC; Deng C; Wang XJ; Zhang Q
Oncogene; 2010 Dec; 29(50):6603-8. PubMed ID: 20818429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
